Context Therapeutics Inc. (CNTX) Insider Trading

Name: Context Therapeutics Inc. (CNTX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 26, 2026): Pasternak Andy (Director): Grant/Award of 45,000 shares.

Get alerted when insiders trade CNTX

Email address

Loading company data...

Beta

Loading company details...

Beta